Archives for September 2008

HelixGene Foundation to Ensure Responsible Reporting of Genomic Medicine

September 28, 2008 | by

Traditional media (i.e. television, print) are the principal sources of science information for the public. This is changing however; adult home broadband users under the age of 30 report that the internet is the most popular source for science news and information [1]. Unfortunately, while the public is consuming science reporting today more than ever before, the media is doing a poorer job covering the field. This is particularly troublesome for genomic medicine and personal genetics, since many physicians who lack training in genomics and genetics frequently get their information from the same mainstream media sources as the public.

Genomic medicine is the use of information from the genome to guide the development of new therapeutics and directly influence patient care.
Personal genetics is the use of a person’s genetic makeup to predict health risks and provide ancestry information.

Closing Arguments on Big Tobacco, Boston Legal Style

September 25, 2008 | by

The ABC television drama Boston Legal is one of my favorite programs. The show features quick, intelligent dialogue and great performances. Producer David E. Kelly has used Boston Legal as a platform to speak out on a number of issues over the last four seasons. Each installment walks a fine line between entertainment and political/social issues such as the Iraq War, global warming and Hurricane Katrina. Tuesday night’s season premier titled “Smoke Signals” was no exception. In this episode, Kelly tackles big tobacco.

The Cancer Genome Atlas Reports Molecular Characterization of Brain Tumors

September 22, 2008 | by

A large-scale, multi-dimensional analysis of the genomic characteristics of glioblastoma, the most common primary brain tumor in adults, provides new insights into the roles of several genes and defines core biological pathways altered in tumor development [1]. The new Cancer Genome Atlas study, published in the September 4th advanced online edition of the journal Nature, also reveals a link between the DNA repair enzyme MGMT and a hypermutation phenotype, and has potential implications for the diagnosis and treatment of glioblastoma.

Glioblastoma is the most common and aggressive type of brain cancer. Patients newly diagnosed with glioblastoma have a median survival of approximately one year with generally poor response to therapy [2]. Gene expression profiling studies suggest multiple subtypes of glioblastoma that, when fully defined, may allow for more personalized therapeutic approaches [3-4].

This is Where the End of Cancer Begins – Stand Up To Cancer

September 5, 2008 | by

“We used to have such wild dreams, the kind that brought us together, made us a movement.

We dreamed we’d split the atom, walk on the moon, unlock our very genetic code.

To those who said ‘impossible’, ‘can’t happen’, ‘won’t happen’, we didn’t hear a word. We stood up and we changed the world.

Stand up, Stand up for everyone who can’t rise anymore. One person every minute, one life in a moment is taken by a disease that we can actually cure. And in the time it’s taken to say these words, one more American has died.

Unforgivable.

This is where the end of cancer begins. When together we rise as one. When we Stand Up To Cancer.”

References

  1. Stand Up To Cancer, television special, CBS Television, U.S.A., Executive producer Laura Ziskin. 2008 Sept 5.

Cancer Research Blog Carnival #13 – Stand Up To Cancer

September 5, 2008 | by

Welcome to the 13th edition of the Cancer Research Blog Carnival, the blog carnival devoted to cancer research.

There’s a revolution occurring on the Web: those “authoritative” articles written on traditional, static websites are being replaced with blogs, wikis and online social networks. In the sphere of health, medicine and information technology, this “real-time Web” consists of many who are professionals in the field; their posts are listed below.
In the digital age, these are the characteristics of new media: recent, relevant, reachable and reliable.

Everyone knows that cancer is a devastating disease. What many people don’t know is that cancer kills more than 1,500 people a day; that’s one person every minute. Tonight, Stand Up To Cancer, a one-hour fundraising event, will be simulcast on all three major U.S. networks. The goal of Stand Up To Cancer (SU2C) is to enable cutting-edge research aimed at finding a cure to all types of cancer and making cancer part of the national debate.

Since 2001, federal deficits resulting from a number of fiscal pressures, including the wars in Afghanistan and Iraq, increased national defense spending and hurricane Katrina, have together placed significant stress on the resources available for U.S. biomedical research. Between the fiscal years 2004 and 2007, the National Cancer Institute’s budget remained relatively flat. However, factoring in inflation (i.e. a Biomedical Research and Development Price Index (BRDPI) of ~3.8% per year) reveals a 12% loss of purchasing power [1].

This decrease in resources comes as patient demand is growing. There was an estimated 1.5 million new cancer cases in 2007, an increase of 14% since 2001 [2]. The U.S. spends roughly $12 billion dollars every month fighting the wars in Afghanistan and Iraq. That’s 33 times more than what is spent on cancer research annually. Imagine what we could do if just a fraction of those resources was dedicated to cancer research.